13F Pro

SEC Form 4 reporting owner

Kantor Susan

Kantor Susan has filed 3 Form 4 transactions reported between December 3, 2025 and February 12, 2026, as Director of Envoy Medical, Inc..

Name as filed: Kantor Susan

Open-market buys, 24 mo
$38K
1 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Feb 12, 2026
transaction date

Roles and reported holdings

  • COCHEnvoy Medical, Inc.
    Dec 3, 2025 – Feb 12, 2026

    Director

    Held directly57,690 sh as of Feb 12, 2026 · Form 4

    24 months: $38K bought

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Feb 12, 2026COCHDirectorOpen-market purchaseCode P · direct57,690—Form 4
Feb 12, 2026COCHDirectorOpen-market purchaseCode P · direct96,150$38K@ $0.4000Form 4
Dec 3, 2025COCHDirectorGrant or awardCode A · direct62,500—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.